These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3887576)

  • 1. Neoplasia in immunosuppressed renal transplant patients: a 20-year experience.
    Krueger TC; Tallent MB; Richie RE; Johnson HK; MacDonell RC; Turner B
    South Med J; 1985 May; 78(5):501-6. PubMed ID: 3887576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive drugs used in clinical renal transplantation.
    Chatterjee SN
    Urology; 1977 Jun; 9(6 Suppl):52-60. PubMed ID: 70101
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of antilymphocyte globulin upon the incidence of malignancies after kidney transplantation.
    Luciani J; Benalia H; Bitker MO; Mouquet C; Chartier-Kastler E; Ourhama S; Jacobs C; Chatelain C; Viars P
    Transplant Proc; 1993 Jun; 25(3):2302. PubMed ID: 8516907
    [No Abstract]   [Full Text] [Related]  

  • 4. Malignancy after immunosuppressive therapy.
    Mazzei D; Polli EE; Quarto di Palo F
    Boll Ist Sieroter Milan; 1977 Mar; 56(2):197. PubMed ID: 326275
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunosuppression in kidney transplantation].
    Grundmann R; Pichlmaier H
    Dtsch Med Wochenschr; 1983 May; 108(18):687-9. PubMed ID: 6341031
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunosuppressive therapy in renal transplantation.
    Popowniak KL; Nakamoto S
    Surg Clin North Am; 1971 Oct; 51(5):1191-204. PubMed ID: 4106550
    [No Abstract]   [Full Text] [Related]  

  • 7. Neoplasia in kidney transplant recipients.
    Sterioff S; Rios CN; Zachary JB; Williams GM
    Am J Surg; 1975 Nov; 130(5):622-6. PubMed ID: 173202
    [No Abstract]   [Full Text] [Related]  

  • 8. Antirejection drugs and procedures.
    Chatterjee SN
    Am J Surg; 1973 Nov; 126(5):678-82. PubMed ID: 4129988
    [No Abstract]   [Full Text] [Related]  

  • 9. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment.
    Kinlen LJ
    Am J Med; 1985 Jan; 78(1A):44-9. PubMed ID: 3970040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hodgkin's disease in a renal transplant recipient. A case report.
    Sterling WA; Wu LY; Dowling EA; Diethelm AG
    Transplantation; 1974 Mar; 17(3):315-7. PubMed ID: 4592187
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of rejection therapy on fungal and nocardial infections in renal-transplant recipients.
    Bach MC; Adler JL; Breman J; P'eng FK; Sahyoun A; Schlesinger RM; Madras P; Monaco AP
    Lancet; 1973 Jan; 1(7796):180-4. PubMed ID: 4118796
    [No Abstract]   [Full Text] [Related]  

  • 12. Prednisone used as treatment for rejection correlates with poor outcome.
    Toussaint RM; Callender CO; Dunston GM; Flores J; Walters CS; John D; Yeager C; Bond O; Thompson C; Gear JC
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1712-5. PubMed ID: 2652561
    [No Abstract]   [Full Text] [Related]  

  • 13. Principles of clinical immunosuppression.
    Santiago Delpin EA
    Surg Clin North Am; 1979 Apr; 59(2):283-98. PubMed ID: 375445
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal transplantation in pediatric patients.
    Lawson RK; Talwalkar YB; Musgrave JE; Campbell RA; Hodges CV
    J Urol; 1975 Feb; 113(2):225-9. PubMed ID: 1089815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organ transplantation-today and tomorrow.
    Cohen SL
    Chic Med Sch Q; 1969; 28(1):33-43. PubMed ID: 4887683
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): its potential to reduce corticosteroids.
    Cantarovich D
    J Nephrol; 2004; 17 Suppl 8():S40-6. PubMed ID: 15599885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective randomized trial of pretransfusion/azathioprine/prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplant recipients: preliminary results.
    Barnhart GR; Hastillo A; Goldman MH; Szentpetery S; Wolfgang TC; Mohanakumar T; Katz MR; Rider S; Hanrahan J; Lower RR
    Circulation; 1985 Sep; 72(3 Pt 2):II227-30. PubMed ID: 3896555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antilymphocyte globulin in cadaveric renal transplantation--a controlled trial.
    Jakobsen A; Sødal G; Flatmark A; Thorsby E
    Scand J Urol Nephrol Suppl; 1977; (42):94-6. PubMed ID: 356233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uses of antilymphocyte globulin in renal transplantation.
    Novick AC
    Urol Clin North Am; 1983 May; 10(2):253-62. PubMed ID: 6344386
    [No Abstract]   [Full Text] [Related]  

  • 20. Late follow-up after thoracic duct drainage in cadaveric renal transplantation.
    Starzl TE; Klintmalm GB; Iwatsuki S; Weil R
    Surg Gynecol Obstet; 1981 Sep; 153(3):377-82. PubMed ID: 7022708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.